BeyondSpring Inc. (BYSI)

↓ Download CSV

CIK 0001677940 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Fiscal year ends Dec 31

In fiscal 2025, BeyondSpring Inc. reported revenue of $0. The company ran a net loss. It held $25.93M in total assets against $49.92M in total liabilities.

Metric (FY)2025202420232022202120202019201820172016
Revenue$0$0$0$1.35M$1.35M$180.0K$0$0$0
Operating Income-$8.95M-$8.75M-$15.08M-$37.24M-$66.24M-$64.21M-$40.31M-$57.55M-$97.98M-$12.37M
Net Income-$1.01M-$11.12M-$21.03M-$33.28M-$64.18M-$60.97M-$38.09M-$54.87M-$91.76M-$12.01M
EPS (Diluted)$-0.02$-0.28$-0.54$-0.85$-1.64$-2.03
Total Assets$25.93M$34.31M$24.81M$46.22M$81.65M$117.04M$44.55M$7.06M$32.83M$14.91M
Total Liabilities$49.92M$48.60M$48.27M$49.23M$55.27M$25.22M$13.42M$16.45M$4.79M$2.61M
Shareholders' Equity-$23.99M-$14.29M-$35.34M-$14.08M$20.92M$86.62M$31.13M-$9.38M$28.04M$12.30M
Cash & Equivalents$7.79M$2.92M$5.40M$34.40M$41.62M$109.54M$35.93M$3.89M$27.48M$11.69M
Operating Cash Flow-$19.77M-$16.44M-$16.47M-$27.46M-$47.24M-$43.74M-$48.16M-$39.95M-$28.80M-$13.70M
Capital Expenditures$50.0K$224.0K$100.0K$34.0K$2.84M$52.0K$4.0K$207.0K$76.0K$64.0K
Shares Outstanding41.12M40.32M39.03M39.00M38.93M39.14M27.89M23.18M22.53M16.88M